Biotech entity
All 1 tracked stories fall under one category: fda-approval. Rajeev Singh Raghuvanshi is most often covered alongside Department of Pharmaceuticals, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Rajeev Singh Raghuvanshi, all published on August 7, 2026.
Last mentioned: Aug 7, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: fda-approval. Rajeev Singh Raghuvanshi is most often covered alongside Department of Pharmaceuticals, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Rajeev Singh Raghuvanshi, all published on August 7, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Rajeev Singh Raghuvanshi. Shared-story counts are live from our verified record — not editorial picks.
The 9th India Medical Device 2026 conference offers biotech and pharma companies a clear signal to diversify into the device sector, as the government pushes for domestic manufacturing and innovation. Regulatory sentiment is shifting to support local production, opening new market adjacencies.
Rajeev Singh Raghuvanshi is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
